SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-021041
Filing Date
2024-04-22
Accepted
2024-04-22 16:38:44
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20024160x2_defa14a.htm DEFA14A 12042
2 logo_appliedtherapeutics.jpg GRAPHIC 31301
3 ny20024160x2-nc_1.jpg GRAPHIC 933336
4 ny20024160x2-nc_2.jpg GRAPHIC 674779
  Complete submission text file 0001140361-24-021041.txt   2197477
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38898 | Film No.: 24861664
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)